04 January, 2000 |
| 09:51 |
Happy New Year to all our Readers |
A. D'Emanuele |
05 January, 2000 |
| 13:07 |
black triangle |
compuph |
| 15:47 |
Re: black triangle |
Brian MATTHEWS |
10 January, 2000 |
| 20:19 |
Fluorinated Pharmaceutical HDPE Bottle |
Levy, Martin |
24 January, 2000 |
| 17:59 |
Expiration dating |
G.Boomish |
25 January, 2000 |
| 18:41 |
DISSOLUTION PROFILE |
T Prasanna Kumar |
31 January, 2000 |
| 16:03 |
Re: Expiration dating |
PharmWeb-Admin |
01 February, 2000 |
| 08:27 |
Expiration Dating |
vng |
02 February, 2000 |
| 14:50 |
Dissolution test for transdermals |
Paola Minghetti |
03 February, 2000 |
| 22:08 |
Aluminium assessment in TPN products |
Joe D'Aprano |
04 February, 2000 |
| 08:55 |
Re: Aluminium assessment in TPN products |
Brian MATTHEWS |
15 February, 2000 |
| 22:39 |
Single Pivotal Clinical Trials |
Henrik Westerlind |
| 22:41 |
Clinical trials in Jordan |
Z Roberton |
16 February, 2000 |
| 08:45 |
Re: Single Pivotal Clinical Trials |
Rui dos Santos Ivo |
| 08:45 |
about cGMP status verification |
dennis Tam |
| 08:46 |
Re: Single Pivotal Clinical Trials |
Brian MATTHEWS |
| 15:30 |
RE: RegAffairs Digest - 11/08/99 |
Caplan Michael MA |
| 15:31 |
Re: about cGMP status verification |
Cgmpman |
| 15:34 |
Re: about cGMP status verification |
Brian MATTHEWS |
| 20:16 |
RE: RegAffairs Digest - 11/08/99 |
admin |
18 February, 2000 |
| 11:01 |
Marketing Authorisations in Israel |
Ross Maclean" (by way of PharmWeb-Admin) |
| 15:21 |
Marketing Authorisations in Israel |
Zoe Roberton" (by way of PharmWeb-Admin) |
19 February, 2000 |
| 13:49 |
Re: Marketing Authorisations in Israel |
Dhalia" (by way of PharmWeb-Admin) |
21 February, 2000 |
| 07:58 |
RAC |
T Prasanna Kumar (by way of PharmWeb-Admin) |
| 10:50 |
Re: RAC |
Brian MATTHEWS" (by way of PharmWeb-Admin) |
22 February, 2000 |
| 08:51 |
RE: RAC |
Chris Marrs" (by way of PharmWeb-Admin) |
| 08:55 |
bulk actives |
girish p. mantgay" (by way of PharmWeb-Admin) |
| 09:51 |
Re: bulk actives |
Brian MATTHEWS" (by way of PharmWeb-Admin) |
07 March, 2000 |
| 14:50 |
<no subject> |
Nancy Falla |
09 March, 2000 |
| 15:51 |
Re: Free Sales Certificate |
Theodor_Poettinger |
13 March, 2000 |
| 15:19 |
CTX and CTC's |
Mohammed Mansaray |
14 March, 2000 |
| 08:58 |
Re: CTX and CTC's |
Brian MATTHEWS |
17 March, 2000 |
| 15:07 |
biotech stability+toxicology studies |
Mohammed Mansaray |
| 18:41 |
Re: biotech stability+toxicology studies |
admin |
21 March, 2000 |
| 13:39 |
lyo product storage |
Mark Roessel |
22 March, 2000 |
| 17:45 |
Analysis of Drug Products |
Merry Joseph |
23 March, 2000 |
| 08:20 |
Re: Analysis of Drug Products |
Brian MATTHEWS |
31 March, 2000 |
| 10:57 |
Re: Analysis of Drug Products |
IVANOW Frédéric |
04 April, 2000 |
| 14:45 |
Regulatory Database - Software |
Lesley Chambers |
| 22:53 |
Re: Regulatory Database - Software |
Stephen Weitzman |
11 April, 2000 |
| 22:28 |
(Auditing) Good Manufacturing Practices for pharmaceutical excipients (distributors) |
e.izeboud |
12 April, 2000 |
| 07:58 |
RE : (Auditing) Good Manufacturing Practices for pharmaceutical excipients (distributors) |
Joseph KWONG Tai-wing |
| 08:01 |
Re: (Auditing) Good Manufacturing Practices for pharmaceutical excipients (distributors) |
Agnes |
| 08:59 |
IPEC |
A. D'Emanuele |
| 14:47 |
Re: (Auditing) Good Manufacturing Practices for pharmaceutical excipients (distributors) |
michael h. anisfeld |
28 April, 2000 |
| 09:31 |
Drug/Device Regs. in Japan |
Jack Samorajczyk |
30 April, 2000 |
| 09:41 |
Product Development Protocol |
Dahibhate P. |
| 09:45 |
Re: Drug/Device Regs. in Japan |
michael h. anisfeld |
| 17:24 |
Re: Drug/Device Regs. in Japan |
default |
01 May, 2000 |
| 18:28 |
Re: Drug/Device Regs. in Japan |
michael h. anisfeld |
04 May, 2000 |
| 09:30 |
Re: Product Development Protocol |
admin |
05 May, 2000 |
| 08:51 |
Registration of Herbals in UK |
Iftikhar Saiyed |
| 16:45 |
Re: Registration of Herbals in UK |
Brian MATTHEWS |
08 May, 2000 |
| 09:11 |
Registration of Herbals in UK |
Dahibhate P. |
11 May, 2000 |
| 14:50 |
Generics vs. brands? |
David Ricks |
| 15:46 |
RE: Generics vs. brands? |
Kupiec, Raun |
| 21:52 |
Re: Generics vs. brands? |
Brian MATTHEWS |
13 May, 2000 |
| 05:53 |
Investigational New Drug supplies labelling |
John Constanza |
18 May, 2000 |
| 09:56 |
polypeptides/proteins |
Joe D'Aprano |
| 13:59 |
Re: polypeptides/proteins |
gfarmer |
| 13:59 |
Re: polypeptides/proteins |
Brian MATTHEWS |
| 14:29 |
RE: polypeptides/proteins |
Kupiec, Raun |
23 May, 2000 |
| 13:42 |
Pharmaceutical QA Programs |
Diana Slemmer |
| 15:09 |
polypeptide/protein drug finished products |
Joe D'Aprano |
| 17:05 |
ICH Q5C |
Joe D'Aprano |
| 17:06 |
Re: Pharmaceutical QA Programs |
james.meakings |
24 May, 2000 |
| 08:21 |
Re: Pharmaceutical QA Programs |
j w rees |
| 08:21 |
Pharmaceutical QA Programs |
j w rees |
| 18:46 |
Rotary dryer qualification |
Arun Kejariwal |
25 May, 2000 |
| 08:20 |
Comparison of generic application between the US & EC |
Dhananjay Panchal |
| 21:24 |
Guidelines for synthetic peptides |
Joe D'Aprano |
26 May, 2000 |
| 08:49 |
Re: Pharmaceutical QA Programs |
michael h. anisfeld |
| 08:51 |
Re: Guidelines for synthetic peptides |
Brian MATTHEWS |
| 10:00 |
Validation of Computer System / Electronic Records / SAP |
Eisele, Johanna |
| 11:41 |
Re: Validation of Computer System / Electronic Records / SAP |
Theodor_Poettinger |
| 13:24 |
Re: Validation of Computer System / Electronic Records / SAP |
james.meakings |
30 May, 2000 |
| 22:48 |
GMP Risk Analysis via FMEA |
Paul Noble |
31 May, 2000 |
| 11:10 |
Re: GMP Risk Analysis via FMEA |
michael h. anisfeld |
01 June, 2000 |
| 16:14 |
cmyc |
Ivan Salazar |
| 21:36 |
Regulatory Issues in Toxicology Screening |
David Hodgson |
05 June, 2000 |
| 08:41 |
Indication of strength in FDCs |
Sjukehusapoteket Elverum |
| 09:27 |
Reg. Affairs within R&D vs. Reg. Affairs as a separate function |
Frederic Ivanow |
| 15:46 |
drinking in gowning room |
Yaakov Adar |
| 20:53 |
FW: cmyc |
Ivan Salazar |
06 June, 2000 |
| 08:35 |
Re: drinking in gowning room |
HoroRL |
| 08:36 |
Unexpected/atypical Results - Investigation |
T Prasanna Kumar |
| 09:04 |
RE: Reg. Affairs within R&D vs. Reg. Affairs as a separate functi on |
Dahibhate P. |
| 15:11 |
RE: drinking in gowning room |
Steve Durfee |
| 23:34 |
Re: Unexpected/atypical Results - Investigation |
michael h. anisfeld |
| 23:35 |
Guidelines for synthetic peptides |
Joe D'Aprano |
| 23:35 |
RE: drinking in gowning room |
gfarmer |
| 23:35 |
Re: Unexpected/atypical Results - Investigation |
HoroRL |
| 23:36 |
Re: drinking in gowning room |
michael h. anisfeld |
07 June, 2000 |
| 08:59 |
Re: drining in gowning room |
Ben Justice |
| 08:59 |
Re: Unexpected/atypical Results - Investigation |
Stanley110 |
| 08:59 |
RE: drinking in gowning room |
Ramli Zainal |
13 June, 2000 |
| 14:28 |
FDA Predicate rules |
Martyn Smith |
26 June, 2000 |
| 08:39 |
carbidopa/levodopa |
Sjukehusapoteket Elverum |
| 10:15 |
Re: carbidopa/levodopa |
Nasshia |
| 10:51 |
RE: carbidopa/levodopa |
Primozic Stanislav |
